Leukocyte Transfusions has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Amphotericin B, Amphotericin B Liposome. Patients taking Leukocyte Transfusions should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 2
Major (2)
- Leukocyte Transfusions + Amphotericin B— Acute pulmonary toxicity has been reported in patients simultaneously receiving intravenous amphotericin B and leukocyte…
- Leukocyte Transfusions + Amphotericin B Liposome— Acute pulmonary toxicity has been reported in patients simultaneously receiving intravenous amphotericin B and leukocyte…